Publications by authors named "Benjamin Brielmaier"

Claim this Profile
I
Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety.
Zhe Han, Natasha N Pettit, Emily M Landon, Benjamin D Brielmaier

Hosp Pharm· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of turnaround time and time to oseltamivir discontinuation between two respiratory viral panel testing methodologies.
Natasha N Pettit, Scott Matushek, Angella Charnot-Katsikas, Vera Tesic, Sue Boonlayangoor, Benjamin Brielmaier

J Med Microbiol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Christopher W Crank, Marc H Scheetz, Benjamin Brielmaier, Warren E Rose, Gourang P Patel

Clin Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micafungin for the prophylaxis and treatment of Candida infections.
Joseph M Fritz, Benjamin D Brielmaier, Erik R Dubberke

Expert Rev Anti Infect Ther· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical experience with anidulafungin at a large tertiary care medical center.
Benjamin D Brielmaier, Ed Casabar, Christine M Kurtzeborn, Peggy S McKinnon, David J Ritchie

Pharmacotherapy· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agent.
Benjamin D Brielmaier

Proc (Bayl Univ Med Cent)· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis